Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multichannel Amplification
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Genome Editing Market Size to Grow USD 6739.8 Million by 2028 at a CAGR of 9.3% | Valuates Reports

This image opens in the lightbox

News provided by

Valuates Reports

05 Sep, 2022, 13:30 GMT

Share this article

Share toX

Share this article

Share toX

BANGALORE, India, Sept. 5, 2022 /PRNewswire/ -- The Global Genome Editing Market is Segmented by Type (CRISPR, TALEN, ZFN), by Application (Animal Genetic Engineering, Cell Line Engineering, Plant Genetic Engineering): Opportunity Analysis and Industry Forecast, 2022–2028. It is published in Valuates Reports under the Biological Sciences Category.

The global Genome Editing market size is projected to reach USD 6739.8 Million by 2028, from USD 3513 Million in 2021, at a CAGR of 9.3% during 2022-2028.

The major factor driving the growth of the Genome Editing market are:

One of the major drivers driving the growth of the genome editing market over the coming few years will be the expanding use of genome engineering in the treatment of chronic illnesses and therapies. The use of genome editing in treating these illnesses has significantly expanded in recent years due to the ongoing incidence of infectious and chronic diseases such as hepatitis, TB, malaria, HIV/AIDS, and others.

The increase in demand for synthetic biology in both developed and developing nations is what is fueling the expansion of the gene editing market. There are several applications for genomics, including the detection of human genetic disorders, medication discovery, agriculture, veterinary sciences, and forensics.

Get Your Sample Today: https://reports.valuates.com/request/sample/QYRE-Auto-5J6164/Global_Genome_Editing 

TRENDS INFLUENCING THE GROWTH OF GENOME EDITING MARKET

The expansion of the genome editing market is anticipated to be fueled by an increase in the number of cancer patients. Due to its ease of usage, CRISPR is quickly becoming a common technology employed in many cancer biology investigations. CRISPR is viewed as a game-changer by scientists for a variety of reasons. The main benefit, especially when compared to more traditional gene-editing methods, is perhaps how simple CRISPR is to employ. Additionally, CRISPR is entirely adaptable. It is more accurate than existing DNA-editing techniques and can essentially modify any DNA segment within the 3 billion letters of the human genome. Additionally, CRISPR gene editing is much quicker.

One of the major drivers driving the growth of the genome editing industry over the coming few years will be the expanding use of genome engineering in the treatment of chronic illnesses and therapies. The use of genome editing in treating these illnesses has significantly expanded in recent years due to the ongoing incidence of infectious and chronic diseases such as hepatitis, TB, malaria, HIV/AIDS, and others. About 1.8 million new infections of HIV were recorded in 2016, according to the CDC. The research community is now developing innovative gene-based medicines to lower morbidity and death in HIV-infected individuals as a result of the rapidly rising number of HIV diagnoses.

Gene-editing technologies' ongoing technological breakthroughs are a key element fueling the market's expansion. Furthermore, it is anticipated that government financing, an increase in the number of genomics studies, and an increase in the prevalence of cancer and other genetic illnesses would all contribute to the Genome Editing market expansion.

The Gene editing market had a positive impact during the pandemic. Rapid diagnostic tests for COVID-19 have been successfully developed using CRISPR technology during the COVID-19 outbreak, receiving their first US FDA (MD, USA) approval in the process. The market is also being driven by the creation of breakthrough diagnostic tools based on CRISPR that will lessen the negative effects of the COVID-19 pandemic.

Browse The Table Of Contents And List Of Figures At: https://reports.valuates.com/market-reports/QYRE-Auto-5J6164/global-genome-editing 

GENOME EDITING MARKET SHARE: 

North America is expected to be the most lucrative region. The industry in North America is primarily being driven by investments in gene therapy research and development, a surge in the usage of GM crops in recent years, and significant technological advancements supported by grants and funding from US government agencies. Due to several government programs and the escalation of genomics research and development (via GAPP) in the nation, the Canadian market is anticipated to expand in the next few years.

The cell line engineering market is expected to be the most lucrative. Cell therapy treatments based on stem cells frequently employ cell-line engineering. However, the advantages of cell line engineering have been investigated in the creation of various biopharmaceutical products such as additional recombinant proteins, vaccines, fusion proteins, growth factors, etc.

CRISPR Segment is expected to account for the largest market share. Comparatively, this technology area is straightforward to understand, simple to use, and reasonably priced. The opportunity for the gene editing market segment will expand with the rising demand for CRISPR/Cas9 for genome analysis to find genetic abnormalities and its therapeutic discovery. Through the application of gene editing, CRISPR technology can be used to treat cancer.

Get Regional Data: https://reports.valuates.com/request/regional/QYRE-Auto-5J6164/Global_Genome_Editing 

Key Companies:

  • Genscript
  • Horizon Discovery Group
  • Lonza
  • Merck KGaA
  • Sangamo Therapeutics
  • Thermo Fisher Scientific

Inquire for Chapter Cost: https://reports.valuates.com/request/chaptercost/QYRE-Auto-5J6164/Global_Genome_Editing 

Buy Now for Single User + Covid-19 Impact :  https://reports.valuates.com/api/directpaytoken?rcode=QYRE-Auto-5J6164&lic=single-user 

SUBSCRIPTION

We have introduced a tailor-made subscription for our customers. Please leave a note in the Comment Section to know about our subscription plans.

SIMILAR REPORTS:

-  Global Digital Genome Engineering Market Insights, Forecast to 2028

-  The global CRISPR Technology market size is projected to reach USD 2929.4 Million by 2028, from USD 845.5 Million in 2021, at a CAGR of 19.1% during 2022-2028.

-  The global CRISPR and CRISPR-Associated (Cas) Genes market size is projected to reach USD 7290.2 Million by 2027, from USD 1000.3 Million in 2020, at a CAGR of 31.9% during 2021-2027.

-  Global Zinc Finger Nuclease Technology Market Insights, Forecast to 2028

-  The global metagenomics market was valued at USD 176 Million in 2017 and is expected to reach USD 523 Million by 2024 at a CAGR of 16.8% from 2018 to 2024.

-  Global Metagenomics Next Generation Sequencing Market Insights, Forecast to 2028

-  China Agrigenomics Market Report & Forecast 2021-2027

-  The global Genomics Personalized Health market size is projected to reach USD 16780 Million by 2028, from USD 9232.4 Million in 2021, at a CAGR of 8.4% during 2022-2028.

-  The global Pharmacogenomics (PGx) market size is projected to reach USD 14590 Million by 2028, from USD 7757.9 Million in 2021, at a CAGR of 9.3% during 2022-2028.

-  The global Pharmacogenomics Technology & Theranostics & Companion Diagnostics (CDx) market size is projected to reach USD 8514.8 Million by 2028, from USD 5180.8 Million in 2021, at a CAGR of 6.9% during 2022-2028.

-  The global Spatial Genomics & Transcriptomics market size is projected to reach USD 282.9 Million by 2028, from USD 184.2 Million in 2021, at a CAGR of 6.2% during 2022-2028.

-  Due to the COVID-19 pandemic, the global Organ-on-a-Chip market size is estimated to be worth USD 80 million in 2022 and is forecast to a readjusted size of USD 581.2 million by 2028 with a CAGR of 39.1% during the review period.

-  In 2020, the global DNA Sequencing market size was USD 13380 Million and it is expected to reach USD 48700 Million by the end of 2027, with a CAGR of 20.4% during 2021-2027.

-  The Global Bioinformatics Market Size is USD 8,614.29 Million in 2019, and is projected to reach USD 24,731.61 Million by 2027, growing at a CAGR of 13.4% from 2020 to 2027.

-  The global Bioinformatics Services market size is projected to reach USD 2967.1 Million by 2027, from USD 1468.2 Million in 2020, at a CAGR of 10.1% during 2021-2027.

-  Global NGS Based Diagnostics Market Insights and Forecast to 2028

-  The Live Cell Imaging Market is anticipated to grow at the rate of 8.9% CAGR by 2027.

-  Global Automated Cell Imaging System Market Size, Status and Forecast 2021-2027

-  The global cell culture market accounted for USD 16,107.7 million in 2019 and is expected to reach USD 36,926.8 million by 2027, registering a CAGR of 10.9% from 2020 to 2027.

-  The global Immortalized Cell Line market size is projected to reach USD 3636.7 Million by 2028, from USD 2461.3 Million in 2021, at a CAGR of 5.3% during 2022-2028.

-  The global next generation sequencing market size was valued at USD 4,533 million in 2018, and is estimated to reach USD 18,565 million by 2026, growing at a CAGR of 19.2% from 2019 to 2026.

-  The global Nutrigenomics market size is projected to reach USD 20990 Million by 2027, from USD 10770 Million in 2020, at a CAGR of 9.5% during 2021-2027.

-  The global Laboratory Information Management System (LIMS) market size is projected to reach USD 1503.3 Million by 2028, from USD 889 Million in 2021, at a CAGR of 7.7% during 2022-2028.

-  The global tissue engineering market size was valued at USD 2374 Million in 2019 and is forecasted to reach a size of USD 6815 Million by 2027 at a CAGR of 14.2% from 2020 to 2027.

-  The global cell separation technologies market size was valued at USD 8,639.20 Million in 2019 and is projected to reach USD 28,766.14 Million by 2027, registering a CAGR of 15.4% from 2020 to 2027.

-  The genetic testing market accounted for USD 12,682 Million in 2019, and is expected to reach USD 21,260 Million by 2027, registering a CAGR of 10.1% from 2020 to 2027.

-  The global cell therapy market accounted for USD 7,754.89 Million in 2019, and is expected to reach USD 48,115.40 Million by 2027, registering a CAGR of 25.6% from 2020 to 2027.

-  The Clinical Diagnostic Market size will be USD 98 Billion in 2028. This is growing at a CAGR of 5.8% CAGR from 2022 to 2028.

ABOUT US:

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

Our team of market analysts can help you select the best report covering your industry. We understand your niche region-specific requirements and that's why we offer customization of reports. With our customization in place, you can request for any particular information from a report that meets your market analysis needs.

To achieve a consistent view of the market, data is gathered from various primary and secondary sources, at each step, data triangulation methodologies are applied to reduce deviance and find a consistent view of the market. Each sample we share contains a detailed research methodology employed to generate the report. Please also reach our sales team to get the complete list of our data sources.

CONTACT US:
Valuates Reports
sales@valuates.com 
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports
LinkedIn - https://in.linkedin.com/company/valuatesreports

Logo: https://mma.prnewswire.com/media/1082232/Valuates_Reports_Logo.jpg 

Modal title

Also from this source

Direct-to-Chip Cooling Market Booms as Data Centers Shift Toward Sustainable Thermal Solutions | Valuates Reports

Direct-to-Chip Cooling Market Booms as Data Centers Shift Toward Sustainable Thermal Solutions | Valuates Reports

Direct-to-Chip Cooling Market is Segmented by Type (Air Cooling, Liquid Cooling), by Application (Data Center, Network Center): Global Opportunity...

Perovskite Solar Cells Market to Reach New Heights with High Efficiency and Low-Cost Energy Tech | Valuates Reports

Perovskite Solar Cells Market to Reach New Heights with High Efficiency and Low-Cost Energy Tech | Valuates Reports

Perovskite Solar Cells Market is Segmented by Type (Rigid Module, Flexible Module), by Application (BIPV, Power Station, Defense & Aerospace,...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Biotechnology

Biotechnology

STEM (Science, Tech, Engineering, Math)

STEM (Science, Tech, Engineering, Math)

Medical Pharmaceuticals

Medical Pharmaceuticals

News Releases in Similar Topics

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.